ATA Safety First Trust Principal-Protected Certificates Linked TO A U.S.-Europe-Japan Basket

Apogee Technology, Inc. (AMEX: ATA), an emerging nanotechnology and micro-systems company that designs, develops and commercializes medical devices and sensor products announced today that Company will present its strategic corporate overview at the Financial Services Exchange ("FSX") Conference scheduled to take place at the Omni Royal Orleans Hotel on July 27-29, 2006 in New Orleans, Louisiana. With the sponsorship of FSX, regional broker/dealers from across the United States are brought together with emerging growth companies to share information and investment opportunities. Founded in 1983, FSX has hosted quarterly investment meetings for more than 25 years. About Apogee Technology, Inc. Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm(TM) solution for enhanced transdermal drug delivery and has introduced a family of pressure sensors. Apogee's goal is to provide value-added and cost-savings solutions for our customers and, in so doing, to become a global leader in the sensors and medical device field. The Company operates a worldwide marketing and sales organization with offices in the US and Japan. For more information please visit our web site at: http://www.apogeemems.com. PyraDerm(TM), Sensilica(TM) and BlueSensor(TM) are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the company to be materially different from those that may be expressed or implied. Please refer to the Company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.